Pond Technologies Holdings Inc. announced the appointment of Anthony J. Giovinazzo, to the Board of Directors. Mr. Giovinazzo's mandate will be to advise Grant Smith, Pond CEO, and the Board of Directors on strategy and capital market aspects of the company's recently announced Biotech Division. Mr. Giovinazzo is currently a Director and Executive Chairman of Sublimity Therapeutics, a private late clinical stage biopharmaceutical company addressing gastrointestinal and autoimmune diseases. He is also a Director of Titan Medical Inc., a company developing robotic assisted technologies for single access surgery. The company also announced that Mr. Cameron Mingay has resigned as Chairman to pursue other interests and that Mr. Robert McLeese has assumed the role of Pond Chairman. Robert McLeese, is the President of Access Capital Corp., a financial advisory firm specializing in the development and financing of independent power projects in Canada and the US. He is the CEO and Chairman of ACI.